Benitec Biopharma Inc.
BNTCNasdaqCIK 1808898HealthcareFiscal year ends Jun 30
Reports and events: 133 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2016:25 ET | DEF 14A | Proxy statementPeriod 2026-10-20 | 0001193125-26-426733 |
| 2026-10-0508:08 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-413177 |
| 2026-09-3016:08 ET | 8-K | 4.01 Change of auditor | 0001193125-26-409052 |
| 2026-09-2416:38 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001193125-26-401110 |
| 2026-09-1416:09 ET | 10-K | Annual reportPeriod 2026-06-30 | 0001193125-26-390570 |
| 2026-09-1416:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-390539 |
| 2026-05-2916:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-248289 |
| 2026-05-1408:10 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-222885 |
| 2026-05-1408:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-222879 |
| 2026-03-2016:03 ET | 10-K/A | Annual report, amendedPeriod 2025-06-30 | 0001193125-26-117604 |
| 2026-02-1208:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-047742 |
| 2026-02-1208:07 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0001193125-26-047737 |
| 2025-12-0217:27 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-305475 |
| 2025-11-1417:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-283351 |
| 2025-11-1417:05 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-283274 |
| 2025-11-1021:53 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000899140-25-001257 |
| 2025-11-0721:29 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-270490 |
| 2025-11-0307:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-261665 |
| 2025-10-1416:58 ET | DEF 14A | Proxy statementPeriod 2025-12-01 | 0001193125-25-239131 |
| 2025-09-2216:53 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-211462 |
| 2025-09-2216:23 ET | 10-K | Annual reportPeriod 2025-06-30 | 0001193125-25-211361 |
| 2025-09-1216:11 ET | 8-K | 4.02 Non-reliance on financial statements | 0000950170-25-114530 |
| 2025-07-0916:16 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-157095 |
| 2025-05-1408:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-119402 |
| 2025-05-1407:09 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001193125-25-119383 |
| 2025-03-2817:13 ET | 8-K | 8.01 Other events | 0001193125-25-067232 |
| 2025-03-2816:50 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000899140-25-000478 |
| 2025-03-2717:10 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-065613 |
| 2025-03-2608:13 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-063235 |
| 2025-03-2017:25 ET | 8-K | 8.01 Other events | 0001193125-25-059398 |
| 2025-03-1907:18 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-057153 |
| 2025-02-1408:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-026659 |
| 2025-02-1407:51 ET | 10-Q | Quarterly reportPeriod 2024-12-31 | 0001193125-25-026631 |
| 2024-12-3106:34 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001193125-24-287065 |
| 2024-12-1316:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-278529 |
| 2024-12-1017:00 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-24-274395 |
| 2024-12-0617:01 ET | 8-K | 5.07 Shareholder vote results | 0001193125-24-272533 |
| 2024-11-1816:36 ET | SC 13D/A | Ownership report, active investor, amended | 0000899140-24-001285 |
| 2024-11-1416:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-258694 |
| 2024-11-1416:32 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001193125-24-258672 |
| 2024-11-1416:31 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-258668 |
| 2024-10-2209:23 ET | DEF 14A | Proxy statementPeriod 2024-12-04 | 0001193125-24-241155 |
| 2024-10-1508:07 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-237227 |
| 2024-10-1116:52 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-236782 |
| 2024-10-0816:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-234458 |
| 2024-09-3017:18 ET | SC 13D/A | Ownership report, active investor, amended | 0000899140-24-001043 |
| 2024-09-2616:43 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-226999 |
| 2024-09-2616:30 ET | 10-K | Annual reportPeriod 2024-06-30 | 0001193125-24-226968 |
| 2024-09-0520:37 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-213348 |
| 2024-07-2916:28 ET | DEF 14A | Proxy statementPeriod 2024-08-29 | 0001193125-24-187599 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 28, 2026, 08:04 ET. Listed shows no prices and gives no investment advice.